BPC-157 in 2026 — where the FDA status and the evidence actually stand

DCDr. Sarah Chen· 2 months ago

Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.

since this comes up weekly: BPC-157 is still not FDA approved and got caught by the 2023 compounding restriction. and as of 2026 there are still zero published human RCTs — it's basically all rodent data, which keeps it tier 3.

people keep mixing up two separate things: "it got restricted" is a regulatory fact, "it works" is an evidence claim the human trials haven't touched. if anyone has a real published human RCT, drop it and I'll happily update this.

3 Replies

RORena Okoro· Senior· 2 months ago

needed saying. "it got restricted" and "it works" are totally separate claims and threads collapse them all the time. the human-trial gap is the same as it's always been.

TRTom R· Researcher· 2 months ago

speaking as someone with an actual injury who would love a shortcut: the animal data is genuinely interesting but wanting it to work isn't evidence. tier 3 is the honest label and I keep reminding myself.

MVMarcus Vale practitioner· Expert· 2 months ago

can we make this the reference thread for the status question. it gets recreated monthly.